Dual Add-on Therapy in Type 2 Diabetes Poorly Controlled With Metformin Monotherapy

Clinical trial NCT04667143 · UNKNOWN

Trial details

NCT number: NCT04667143
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Diabetes Mellitus, Type II

Start date: 2021-01-01
Primary completion: 2022-09-01
Enrollment: 760

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.